NAME: PanTumor3- Biliary Tree
What type of cancer is this for: Liver, gallbladder, bile ducts
Phase: II
Who is this trial for: Men and women who have cancer in their biliary tract: liver and/or gallbladder and/or bile ducts that has spread to other parts of the body and cannot be taken out.
What biomarkers are involved? Your cancer cells must be positive for Trop2
What is National Clinical Trial #? NCT05489211
Brief summary of trial: This trial is looking to see how well the study drug (Dato-DXd) works on biliary tract cancers that have spread, as well as how safe the drug is.
Need to know: You need to have tried either Gemzar & Carboplatin OR Gemzar & Cisplatin in the past.
Where is this trial available? The Cancer & Hematology Centers
For more information, please call 616-975-3065 or email [email protected]
NAME: IMBRAVE 152
What type of cancer is this for? HEPATOCELLULAR (LIVER) cancer
Phase of this trial? Phase III
Who is this trial for? Men and women with liver cancer that has spread either locally or to other parts of the body.
What biomarkers are involved? None
What is the National Clinical Trial #? NCT05904886
Brief summary of trial: This study will evaluate how well the study drug (tiragolumab) works and how safe it is, compared to an existing known therapy.
Need to know: You may have had treatment for your liver cancer before it spread, but now that it has spread, this has to be the first treatment you receive for it.
Where is this trial available?: The Cancer & Hematology Centers and other sites nationwide, please click on link above to review.
For more information, please call 616-975-3065 or email [email protected]